Labcorp to buy select assets from Opko Health unit for up to $872 million
Oct 15 (Reuters) — Laboratory operator Labcorp said on Thursday it will buy some assets from Opko Health's subsidiary in a $722 million cash deal, with a potential additional payment of up to $150 million tied to revenue from a prostate cancer test. Shares of Opko Health were up 20% in premarket trading. Here are some